Erythropoietin: Elucidating new cellular targets that broaden therapeutic strategies
- 4 March 2008
- journal article
- review article
- Published by Elsevier in Progress in Neurobiology
- Vol. 85 (2) , 194-213
- https://doi.org/10.1016/j.pneurobio.2008.02.002
Abstract
No abstract availableKeywords
This publication has 369 references indexed in Scilit:
- Trends in oxidative aging theoriesFree Radical Biology & Medicine, 2007
- STAT dynamicsCytokine & Growth Factor Reviews, 2007
- Wnts: up-and-coming at the synapseTrends in Neurosciences, 2007
- Erythropoietin prevents PC12 cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis via the Akt/GSK-3β/caspase-3 mediated signaling pathwayApoptosis, 2007
- Cellular demise and inflammatory microglial activation during β-amyloid toxicity are governed by Wnt1 and canonical signaling pathwaysCellular Signalling, 2007
- GSK-3 is a viable potential target for therapeutic intervention in bipolar disorderNeuroscience & Biobehavioral Reviews, 2007
- A Conserved MST-FOXO Signaling Pathway Mediates Oxidative-Stress Responses and Extends Life SpanCell, 2006
- New Avenues of Exploration for ErythropoietinJAMA, 2005
- Activation of the transcription factor NF-κB by the erythropoietin receptor: Structural requirements and biological significanceCellular Signalling, 2001
- Changes in left ventricular size, wall thickness, and function in anemic patients treated with recombinant human erythropoietinAmerican Heart Journal, 1992